ECOG 2597 A Phase III Trial Of Induction Paclitaxel and Carboplatin followed by Standard Radiotheray (64 GY/7 weeks) vs. Hyperfractionated Accelerated Radiotherapy (HART 57.6 Gy/2.5 weeks) for Patients with Unresectable Stage IIIA and IIIB Non-Small Cell Lung Cancer.
RTOG 98-01 A Phase III randomized Study of Amifostine Mucosal Protection for Patients with Favorable Performance Inoperable Stage II-IIIA/B Non-small Cell Lung Cancer (NSCL) Receiving Sequential Induction and Concurrent Hyperfractionated Radiotherapy with Paclitaxel and Carboplatin.
Supportive Care
RTOG 97-14 Randomized Trial of Palliative Radiation Therapy For Osseous Metastases: A Study Of Palliation Of Symptoms and Quality Of Life.
[ top ]
|
|
|
Research Information
|
|
| |
|
 |
|
